COVID-19 AND CHILDREN: COMPLICATIONS AND LATE OUTCOMES

M Zhvania1, M Kvezereli-Kopadze1, T Kutubidze1

  • 1Tbilisi State Medical University, G. Zhvania Pediatric Academic Clinic, Georgia.

Insights

Even asymptomatic COVID-19 in children can lead to late complications, including multisystem inflammatory syndrome (MIS-C). Pediatricians must monitor children post-infection for these potential long-term health issues.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • COVID-19 presents a global health challenge, particularly for pediatric populations.
  • While often mild or subclinical in children, COVID-19 can result in severe late-onset complications.

Purpose of the Study:

  • To investigate the spectrum and characteristics of post-COVID-19 complications and late COVID syndrome in children.
  • To identify common comorbidities and specific syndromes like MIS-C in pediatric patients following SARS-CoV-2 infection.

Main Methods:

  • Retrospective observational study of 60 children with post-COVID complications and late COVID syndrome at a tertiary pediatric clinic.
  • Analysis of clinical data, medical history, serological markers (including antibody tests, ANA, ANF), and patient outcomes.

Main Results:

  • Over half of the 60 children studied were under 5 years old; 85% were previously healthy.
  • Documented complications included vasculopathy, immune thrombocytopenia, anemia, coagulopathy, pneumonia, and exacerbation of underlying conditions.
  • Eight children (13%) presented with multisystem inflammatory syndrome in children (MIS-C), some exhibiting Kawasaki disease-like symptoms, with one developing a coronary artery aneurysm.

Conclusions:

  • Post-COVID-19 complications and late COVID syndrome can occur even after asymptomatic or mild SARS-CoV-2 infections in children.
  • Thorough examination and dynamic monitoring are crucial for pediatric patients following COVID-19 to detect and manage potential long-term sequelae.
  • The study highlights the importance of recognizing MIS-C and other inflammatory conditions in the pediatric post-COVID landscape.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
548
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48